Background. Mice (n=58) with abdominal heterotopic heart transplants were studied to examine the effectiveness of "'in-labeled antimyosin scintigraphy in the detection of rejection and to determine the consequence of cyclosporine therapy on the results.
Methods and Results. Allografts from B10D2 donors were transplanted into B6AF1 recipients. Of the 49 allografted mice, 19 were treated with cyclosporine (15 mg/kg.day). Nine isografted mice served as controls. Scintigraphy was performed by injecting 100 ,uCi "'In antimyosin monoclonal antibody 2-15 days after transplantation. An increase in the ratio of percent dose of antimyosin injected per gram (% dose/g) of the grafted heart (G) to that of the autologous heart (A) (G/A) as well as the increasing percent dose per gram of antimyosin in the grafts reflected the severity of histopathological rejection regardless of the presence or absence of cyclosporine. Scintigraphic images demonstrated unequivocally intense accumulation of "'In in rejected allografts as confirmed by histologically demonstrable myocyte necrosis. The G/A ratio in allografted mice with mildly deteriorated mechanical activity (4.2± 1.0, mean± SD) was greater than that in mice with normal contractility (1.8+0.7) (p<O.OOl), and the necrosis correlated with this modest decline in mechanical function could be scintigraphically identified. Of mice with normally contracting allografts, the G/A ratio was greater in animals with demonstrated myocyte necrosis (2.6±+0.5) than in those without necrosis (1.5+±0.5) (p<O.OOl). In contrast, isografted mice or a subset of allografted mice treated with cyclosporine and not showing evidence of rejection did not manifest any significant change in G/A ratio, nor did they have scintigrams positive for rejection as late as 15 days after transplantation.
Conclusions. These findings suggest that antimyosin scintigraphy is a sensitive and early indicator of cardiac transplant rejection and that it could be useful as a noninvasive method for assessing the efficacy of cyclosporine treatment. (Circulation 1991 (Circulation :84:1246 (Circulation -1255 E arly detection of allograft rejection is crucial in the care of patients after heart transplantation. A definitive diagnosis of rejection currently requires repeated endomyocardial biopsies as well as their interpretation by a highly experienced pathologist. 12 To avoid risk and discomfort to the patient, a variety of noninvasive approaches for assessing cardiac allograft rejection have been explored, including echocardiography,3 cytoimmunologic monitoring,4 nuclear magnetic resonance imaging,5.6 nuclear scintigraphy with radiolabeled lymphocytes,7.8 and scintigraphy with radiolabeled antimyosin monoclonal antibody. [9] [10] [11] [12] [13] We previously demonstrated that cardiac localization of monoclonal antimyosin antibodies is correlated with myocardial necrosis, whether caused by acute myocardial infarction14.15 or myocarditis. 16, 17 Because cardiac allograft rejection is also associated with histologically apparent myocyte necrosis,2 it was logical to explore the applicability of this method in the diagnosis of rejection, which has been done in both an experimental model10 and patients.912 Although some studies in dogs10 and rats13 showed antimyosin accumulation in rejecting cardiac allografts, other investigations did not support this finding.'1 Furthermore, the reported experiments did not define whether antimyosin imaging could be used as an early marker of acute rejection, or whether cyclosporine, apart from its effect on the rejection process, affected accumula-tion of the antibody in cardiac allografts. Therefore, the present study was designed to evaluate the relation between uptake of labeled antimyosin and histological degree of rejection, determine whether antimyosin imaging can detect rejection at a stage earlier than the decline of mechanical activity in the transplanted heart, and evaluate whether the immunosuppressive effects of cyclosporine therapy alter antimyosin uptake in the rejecting heart.
Methods

Animals
Male, inbred B1OD2 and B6AF1 mice were obtained from the Jackson Laboratory (Bar Harbor, Me.). CD-1 mice were purchased from Charles River Breeding Laboratory (Boston).
Organ Grafting
Heterotopic Recipientpreparation. The recipient mice were prepared as described above. The abdomen was shaved, and a midline abdominal incision was made. The intestine was then exteriorized and wrapped with wet gauze. The abdominal aorta and inferior vena cava were gently separated below the branching of the renal vessels using cotton-tipped applicators and forceps. All small lumbar vessels were ligated with 6-0 silk. Proximal control of the inferior vena cava was obtained by ligature with 6-0 silk, and the abdominal aorta was secured with a Yasargil artery clamp. Distal control was established en masse with 6-0 silk ligature. After closely adjacent venotomy and aortotomy were effected by microscissors, the donor heart was placed within the abdominal cavity. An end-to-side anastomosis was then made by running suture with a 10-0 nylon strand (Ethilon) tipped with a BV75-3 needle. After the anastomoses had been completed, the distal and proximal ligatures and a clamp were loosened, in this order, slowly and carefully. At this point, the grafted hearts became pink and began to contract within a few seconds of reperfusion, after which rhythmic contraction was restored. Warm saline was then dripped onto the graft. After the confirmation of continuous strong beats in the graft, the abdominal wall was closed with 6-0 silk. The animal was then warmed under a heat lamp. The ischemic time was defined as the interval between the injection of cardioplegia solution into the donor heart and reperfusion.
Experimental Groups
Cyclosporine (Sandoz, Inc., Basel, Switzerland) (15 mg/kg) was injected subcutaneously daily beginning on the day of surgery in 26 allografted mice. Four of 37 allografted mice without cyclosporine, three of 26 allografted mice with cyclosporine, and one of 12 isografted mice died within 2 days after transplantation and were excluded from the analysis.
Heartbeat
The function of the transplanted hearts was assessed daily by direct palpation, and mechanical activity was graded independently by two examiners. One examiner was blinded to the animal's treatment group, and interobserver agreement was more than 90%. Our preliminary experience and a report from another laboratory'9 show that a sharp decline in the intensity of the cardiac impulse is a reliable sign of rejection. The quality of the heartbeats was graded from 0 to 4+ (4+ being optimal and 0 being complete arrest). Grades 4+ and 3+ were considered normal, and grades 2+, 1+, and 0 were interpreted as signs of rejection. Scintigraphy
The preparation of antimyosin monoclonal antibody 2G42D7 has been reported previously. 20 comparison with that in the native heart after an area of interest had been set by computer planimetry.
Tissue Analysis
Mice were killed after scintigraphy, and venous blood was withdrawn from the inferior vena cava. The autologous heart, transplanted heart, liver, spleen, kidneys, lungs, and small intestine were excised. Both hearts were washed thoroughly with saline and immersed in 10% formalin. Each organ was weighed, and the biodistribution of radioactivity in the organ was determined by gamma scintillation counting. Localization was expressed as the percent injected dose per gram of wet tissue (% dose/g). The ratio of percent dose per gram of the grafted heart (G) to that of the autologous heart (A) was determined for each mouse and designated G/A ratio. We regarded`I11n-labeled antimyosin activity in the autologous heart as background antibody uptake by normal myocardium.
Duration of Ischemia and Antimyosin Uptake
The duration of ischemia in the donor heart has been shown to be a crucial factor of myocyte necrosis in the murine ectopic heart transplantation model.23-25 The effect on antimyosin uptake of myocyte necrosis resulting from ischemia during surgery was investigated in 20 isografted mice (B1OD2 or B6AF1). Heart transplantation was performed as described above. Mice were randomly assigned to one of four groups (A, B, C, and D) containing five mice each. Reperfusion was performed 30 minutes after resection of the donor hearts in group A, 60 minutes in group B, 90 minutes in group C, and 120 minutes in group D. Five minutes after reperfusion, the mice were injected with approximately 100 ,uCi 1`In-labeled antimyosin. Fifteen minutes later, grafted and autologous hearts were resected, and the G/A ratio was determined for each mouse.
Histological Examination
Grafted and autologous hearts were embedded in paraffin and stained with hematoxylin and eosin. The samples were submitted for blinded histopathological evaluation by a pathologist and classified into one of four groups according to the degree of rejection2 as follows: normal, mild rejection, moderate rejection, and severe rejection. The mice with moderate rejection were divided into two groups according to the presence or absence of myocyte necrosis.
Statistical Analysis
The Bonferroni method was used for multiple comparisons.26 A On the basis of these observations, we excluded nine grafts for which the ischemia time during surgery was more than 60 minutes. Some of these excluded mice showed abnormally high antimyosin uptake compared with their histological degree of rejection. This exclusion criterion reduced the study groups to 30 allografts without cyclosporine, 19 allografts with cyclosporine, and nine isografts. Histopathology A broad spectrum of histological findings was present among the 49 allografts, ranging from nearly normal to severe rejection ( Figure 1) . Regardless of the time after transplantation and the presence or absence of cyclosporine therapy, antibody uptake increased with increasing severity of rejection (Table  1 and Figures 2 and 3 ). Mice with mild or moderate rejection in the absence of necrosis showed no statistical increase in G/A ratio or percent dose per gram compared with mice determined to be normal by histology. However, mice with severe or moderate rejection and the presence of necrosis showed significant increases in both G/A ratio and percent dose per gram of grafted heart compared with mice with no, mild, or moderate rejection without necrosis. Sensitivity and specificity (G/A ratio of more than 2.0 [mean value for isografts+ 1 SD] was considered positive) for the detection of myocyte necrosis in all mice were 86% and 91%, respectively. Regarding the detection of rejection (regardless of degree), sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy were 57%, 91%, 96%, 33%, and 64%, respectively. Sensitivity and specificity for discrimination between rejecting grafts without myocyte necrosis and normal grafts were 11% and 91%, respectively. In cyclosporine-treated animals, sensitivity and specificity for the detection of myocyte necrosis were each 100%.
Three of the allografts among the 19 mice that were treated with cyclosporine showed histologically severe rejection. Both G/A ratio (3.79, 2.78, and 7.14) and percent dose per gram of grafted heart (14.7%, 10.3%, and 11.2%, respectively) in these three mice were greater than those of any other allografted mice with cyclosporine therapy or those of isografted mice. In contrast, the GIA ratio of mice treated with cyclosporine but without histological evidence of necrosis was 1.81 or less, which was as low as that of the isografted mice.
Time Course of '`In Antimyosin Uptake
The G/A ratio increased progressively with time in allografted mice that did not receive cyclosporine therapy (r=0.64,p<0.001) (Figure 4) . In contrast to the progression in the G/A ratio in these allografted mice, the isografted mice showed no significant increase in the G/A ratio as late as 14 days after transplantation. Figure 5 shows the time course of the G/A ratio in cyclosporine-treated allografts.
Allografted animals not treated with cyclosporine were divided into three groups according to the time between transplantation and tissue counting: 2-4 days (n=8), 5 -9 days (n11), and 10-14 days (n= 11). As shown in Table 2 , the G/A ratio in the group that was killed early (2-4 days) was not significantly different from that of the isografted group. However, in the 5-9-and 10-15-day groups, the G/A ratio was significantly greater than that of the isografted animals (p<0.001 and p<0.01, respectively).
Heartbeat
In all nine isografted mice, 16 (3 + to 4+) in the grafts when the animals were killed. The G/A ratio in the six allografted mice that showed mildly impaired contraction (2+) (4.2±1.0) was greater than that in allografted mice with normal contraction (1.8+0.7) (p<0.001) (Figure 6 Sensitivity, specificity, and 'accuracy for detecting deterioration in the mechanical activity of a graft were 100%, 73%, and 81%, respectively. All 17 grafts with a grade 1 + or 2+ heartbeat and nine of 41 grafts with normal contractility revealed myocyte necrosis. When allografted mice with normal contractility were divided into two groups according to the presence or absence of histological evidence of necrosis, the G/A ratio in mice with no necrosis (1.5 +0.5) was significantly lower than that in mice with necrosis (2.6+0.5) (p<0.001) (Figure 7) . 
Scintigraphy
Antimyosin scans showed unequivocal accumulation of the tracer in allografts with high G/A ratios. A good correlation was observed between the G/A ratio measured by tissue counting and the ratio measured by computer planimetry from the scintigrams (P=0.42xG/A+1.3, r=0.87, n=49, p<0.001, where P is ratio of radioactivity in the graft to that in the autologous heart measured by computer planimetry). (Nine mice in which images of the grafts overlay those of the kidneys were excluded from this evaluation.) Correlation between the intensity of radiotracer signal from the scintigram and the percent injected dose per gram (%ID) was also good (P=0.12x%ID+1.45, r=0.79, n=49,p<0.001). Representative images are shown in Figures 8-11 . Allografted mice treated with cyclosporine without histological evidence of rejection showed no specific accumulation of radiolabeled antimyosin at any time after transplantation, whereas three mice with histological evidence of rejection as well as increased G/A ratios showed considerable uptake of radioactivity. Compared with autologous hearts, radioactivity (measured by computer planimetry) in severely rejecting grafts was significantly greater than that in grafts from any other group (Table 1) . Radioactivity in moderately rejecting grafts with myocyte necrosis was greater than that in mildly rejecting or normal grafts. The ratio of radioactivity in the graft versus autologous heart also reflected mechanical activity in the graft. The ratio in mice with normally beating grafts (2.0+0.7, n=33) was less than that in mice whose graft heartbeat had deteriorated mildly (3.0+1.0, n=6, p<0.01) or severely (3.9+1.2, n=10,p<0.001).
Biodistribution of Injected Antimyosin
The biodistribution of`11In antimyosin (% dose/g) in all organs was as follows: autologous heart (3.1+0.9%), liver (25.6±11.0%), spleen (7.7+3.8%), right kidney (17.1+7.9%), right lung (3.8±2.5%), NORMAL MILD SEVERE FIGURE 6. Bar graph of ratio ofpercent dose of antimyosin of grafted heart (G) to that of autologous heart (A) (GIA) compared with myocardial contractility. GIA ratio increases according to deterioration ofmechanical activity of allografts. bowel (3.4+1.4%), and blood (3.0+4.6%). There was no statistical difference in the percent dose per gram of these organs among nontreated allografted, treated allografted, and isografted mice. The percent dose per gram of grafted hearts is listed in Table 2 .
Discussion
Results from the present study demonstrate that scintigraphy with`111n-labeled antimyosin antibody accurately -detects the existence of acute cardiac rejection. The degree of accumulation of 11in-labeled antimyosin in rejected hearts also reflects the magnitude of rejection by histological criteria. Antimyosin uptake precedes the decline in mechanical activity of the transplanted heart. Furthermore, the degree of uptake is not affected by cyclosporine therapy but rather reflects the extent of myocyte necrosis resulting from rejection. These findings are reflected in the gamma scintigram.
The ability to detect cardiac allograft rejection noninvasively could play an important role in the GIA ratio in mice with and without histological evidence of myocyvte necrosis. Eight of 24 mice with apparently normal mechanical activity had evidence of mycvyte necrosis; GIA ratio in these eight mice is significantly greater than GIA ratio in the remaining 16 mice that did not show myocyte necrosis. management of patients who undergo heart transplantation. Rejection should be detectable before a decline in mechanical activity, and the diagnosis should be sensitive, specific, and effective even in the presence of immunosuppressive therapy with cyclosporine. Although several scintigraphic approaches for the diagnosis of rejection, such as "mTc-pyrophosphate,7 1T1,2829or`In lymphocytes,78 hav been reported, none has proved clinically satisfactory.30 -32 We previously showed that radiolabeled antimyosin antibody localizes in histochemically delineated regions of myocyte necrosis. ' than 60 minutes to minimize the effect of antimyosin uptake caused by intraoperative ischemic myocyte necrosis. The fact that isografts or nonrejected allografts showed no increase in antimyosin uptake as late as 15 days indicates that antibody uptake correlates with rejection-associated myocyte necrosis. Thus, the potential for false-positive scans caused by perioperative infarction could be excluded in our experiment.
As shown by Corry et al,19 B10D2 mice rapidly reject hearts from B6AF1 mice. In their study of seven mice with transplanted hearts, a sharp decline in impulse was observed between 7 and 22 days (median±SD time of sharp decline, 11.5-1.1 days) after surgery. In the present study, allografted mice were killed 2-15 days after transplantation. Although some mice showed significant reduction in the intensity of cardiac impulse at the time of termination, none showed a complete absence of impulse.
Uptake of antimyosin (percent dose of`I1n antimyosin per gram of grafted heart and G/A ratio) generally reflected the degree of rejection by histological criteria. FIGURE 10 . Scintigrams of isografted mice 8 days (left panel) and 9 days (ight panel) after transplantation. Ratios ofpercent dose ofantimyosin ofgrafted heart to that of autologous heart are 1.5 and 1.4, respectively. L, liver; K kidney; A, autologous heart; G, graft. In nontreated cardiac allografts, antimyosin antibody accumulated progressively during the course of rejection. Reflecting the demonstrated antibody accumulation, antimyosin scintigraphy proved to be a sensitive indicator of myocyte necrosis.
Ballester-Rodes et al12 studied the usefulness of antimyosin scintigraphy in detecting cardiac rejection in patients. They used a ratio of cardiac graft to adjacent lung background to quantitate uptake in sequential scans and regarded a heart-to-lung ratio of more than 1.6 as a positive scan. In experimental models of cardiac allograft rejection in dogs10 and rats,13 an uptake G/A ratio was used as the parameter for quantitation. These investigations showed that a ratio of more than 1.4 or 2.3 predicted the presence of moderate or severe histological rejection, respectively, which corresponds closely to the results reported here. It is of interest that regardless of differences in species studied or methods used, mild and moderate rejection are defined at similar graftto-background antibody uptake ratios.
Mechanical dysfunction in the transplanted heart is the most serious outcome of cardiac rejection. How- ever, the relation between deterioration in mechanical activity in allografts and uptake of labeled antimyosin has not been investigated previously. Antimyosin uptake is significantly increased in rejecting allografts with deteriorating mechanical activity compared with allografts with normal mechanical activity. We found that some mice with histological evidence of necrosis resulting from acute rejection showed apparently normal cardiac contractility. Even in these mice, the G/A ratio was significantly greater than the ratios in mice with histologically normal grafts. Although it should be noted that the direct palpation of grafts is a rough, subjective estimate of mechanical performance, these results suggest that accumulation of antimyosin is a more sensitive early detector of rejection than is decline in mechanical activity.
Cyclosporine (15 mg/kg-day) suppressed rejection in the majority of allografted mice. As shown in Figure 5 , the G/A ratio remained low as late as 15 days after transplantation, with the exception of three mice. Histological examination revealed severe rejection in these three allografts. Scintigrams in these three animals showed significant accumulation of radioactivity in the allografts in comparison with cyclosporine-treated allografted mice without histological evidence of necrosis. The absence of nonspecific positive scan or false-negative scan during the period of cyclosporine administration attests to the usefulness of antimyosin scintigraphy during cyclosporine therapy. These results suggest that despite the limited scope of this evaluation, antimyosin scanning may be helpful in monitoring the effects of cyclosporine therapy.
Our experiments demonstrate that antimyosin scintigraphy can be used to detect cardiac rejection in the presence of myocyte necrosis, that the efficiency of antimyosin scintigraphy is not affected by cyclosporine treatment, and that antimyosin scintigraphy reflects the degree of severity of rejection by histological assessment. Myocyte necrosis is a relatively advanced indicator of acute cardiac transplant rejection, yet because many transplant patients receive intensive immunosuppressive therapy only after myocyte necrosis has been demonstrated by endomyocardial biopsy,34,35 a noninvasive test that clearly demar-cates myocyte necrosis could benefit these patients. It appears that clinical trials of antimyosin scintigraphy in the monitoring of patients who have undergone heart transplantation are indicated.
